Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7human papillomavirus vaccine, L1 type 16, 18 6Papillomavirus Vaccines 4Vaccines 2Engerix-B 2adacel 1Vaccines, Synthetic 1Tetanus Toxoid 1Methods 1Hepatitis A Vaccines 1Educational Status 1Early Intervention, Educational 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Papillomavirus Infections × Diphtheria-Tetanus-acellular Pertussis Vaccines × Clear all
NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting
27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡